
Bristol Myers Squibb (BMS) is a global biopharmaceutical company that develops innovative therapies across oncology, hematology, immunology, cardiovascular disease, and fibrosis. Leveraging a sustainable pipeline, translational medicine, and advanced data analytics, BMS delivers precision medicines designed to meet patients' needs at the right time. The company fosters a culture of collaboration and diversity, empowering scientists, business, and support teams to pursue breakthrough ideas and grow professionally. Through its Foundation and corporate initiatives, BMS also commits to health equity, aiming to improve outcomes for populations disproportionately affected by serious diseases.
The Senior Director, Global/US Medical Affairs Oncology, Pumitamig GI/GU Cancers, provides scientific and strategic leadership for Pumitamig across GI/GU cancers within a highly integrated Alliance partnership.
Bristol Myers Squibb (BMS) is a global biopharmaceutical company that develops innovative therapies across oncology, hematology, immunology, cardiovascular disease, and fibrosis. Leveraging a sustainable pipeline, translational medicine, and advanced data analytics, BMS delivers precision medicines designed to meet patients' needs at the right time. The company fosters a culture of collaboration and diversity, empowering scientists, business, and support teams to pursue breakthrough ideas and grow professionally. Through its Foundation and corporate initiatives, BMS also commits to health equity, aiming to improve outcomes for populations disproportionately affected by serious diseases.
Bristol Myers Squibb